BofA raised the firm’s price target on PTC Therapeutics (PTCT) to $87 from $76 and keeps a Buy rating on the shares. The firm’s survey of 20 ...

Vishay Intertechnology, Inc. (NYSE: VSH) today introduced a new series of insulated, surface-mount inrush current limiting ...

Dealing with inrush currents in industrial systems? PTC thermistors can handle higher energy, reduce component count & ...

PTC (NASDAQ: PTC) has outperformed the market over the past 10 years by 7.24% on an annualized basis producing an average annual return of 20.37%. Currently, PTC has a market capitalization of $24.39 ...

This was the stock's second consecutive day of losses.